Tag: MOSY

  • Stocks To Watch: MoSys Inc. (NASDAQ:MOSY), Lime Energy Co. (NASDAQ:LIME), Genetic Technologies Limited (ADR) (NASDAQ:GENE), MEI Pharma Inc (NASDAQ:MEIP)

    On May 2, MoSys Inc. (NASDAQ:MOSY) reported financial results for the first quarter ended March 31, 2014. Secured multiple new design wins for Bandwidth Engine® ICs; Increased production shipments of Bandwidth Engine ICs quarter-over-quarter; Achieved carrier-grade qualification of Bandwidth Engine 2 product family; Announced production availability of all three Bandwidth Engine 2 products; Introduced third generation Bandwidth Engine architecture; and Ended the quarter with total cash and investments of $45.7 million. MoSys Inc. (NASDAQ:MOSY) weekly performance is -11.67%. On last trading day company shares ended up $3.33. Analysts mean target price for the company is $6.17. MoSys Inc. (NASDAQ:MOSY) distance from 50-day simple moving average (SMA50) is -24.86%.

    On May 6, 2014, Lime Energy Co. (NASDAQ:LIME) announced that it will file its 2014 first quarter statements after the market close on Wednesday, May 14th. The same day Lime Energy will hold a conference call at 4:30 pm eastern time to discuss these results. Lime Energy Co. (NASDAQ:LIME) shares advanced 0.37% in last trading session and ended the day on $2.72. LIME Gross Margin is 26.70% and its return on assets is -76.10%. Lime Energy Co. (NASDAQ:LIME) quarterly performance is -9.93%.

    On Apr 30, 2014, Genetic Technologies Limited (ADR) (NASDAQ:GENE) announced it has filed its Quarterly Activities Report for the Quarter ended March 31, 2014 in accordance with the ASX. Total cash receipts from customers during the quarter ended March 31, 2014 were $1.4 million taking the equivalent figure to more than $3.7 million for the nine-month period ended on that date. Genetic Technologies Limited (ADR) (NASDAQ:GENE) shares moved down -3.77% in last trading session and was closed at $1.02, while trading in range of $0.97 – $1.06. Genetic Technologies Limited (ADR) (NASDAQ:GENE) year to date (YTD) performance is -28.67%.

    MEI Pharma Inc (NASDAQ:MEIP), announced that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences: The Bank of America Merrill Lynch Health Care Conference on Thursday, May 15, 2014 at 12:40 p.m. Pacific time from the Encore at the Wynn in Las Vegas; and The UBS Global Healthcare Conference on Tuesday, May 20, 2014 at 9:00 a.m. Eastern time from the Sheraton New York Times Square Hotel. MEI Pharma Inc (NASDAQ:MEIP) ended the last trading day at $6.92. Company weekly volatility is calculated as 6.83% and price to cash ratio as 2.50. MEI Pharma Inc (NASDAQ:MEIP) showed a negative weekly performance of -5.85%.